
More on Archer Daniels Midland ( ADM ) FQ2 : net profit plunges 89% to $80M, which includes the impact of LIFO, PHA -related impairment charges. "Ongoing weakness in global oilseeds margins, lower results in corn and poor industrial merchandising
obamacare screwing things up already More than 60 doctor-owned hospitals across the country that were in the development stage will be canceled, said Molly Sandvig, executive director of Physician Hospitals of America ( PHA ). “That’s a lot of access to communities that will be denied,” Sandvig told CNSNews.com. “The existing hospitals are greatly affected. They can’t grow. They can’t add beds. They can’t add rooms. Basically, it stifles their ability to change and meet market needs. This is really an unfortunate thing as well, because we are talking about some of the best hospitals in the country.” The organization says physician-owned hospitals have higher patient satisfaction, greater control over medical decisions for patients and doctor, better quality care and lower costs. Further, physician-owned hospitals have an average 4-1 patient-to-nurse ratio, compared to the national average of 8-1 for general hospitals. Further, these 260 doctor-owned hospitals in 38 states provide 55,000 jobs, $2.4 billion in payroll and pay $509 million in federal taxes, according to the PHA . In one ironic aspect, President Barack Obama’s two largest legislative achievements clashed. The Hammond Community Hospital in North Hammond, Ind., got $7 million in bond money from the federal stimulus act in 2009. It will likely be scrapped because of the new rules on physician-owned hospitals, according to the Post-Tribune newspaper in Merrillville, Ind. These hospitals have long been a target of the American Hospital Association, which represents corporate-owned hospitals as well as non-profit hospitals. LOL!!!!!
Pfizer PFE and Pharmacia PHA announced Monday that they have reached an agreement with the Federal Trade Commission, clearing the path for their merger to
The COX-2 patent win for Pfizer PFE and Pharmacia PHA , announced Wednesday, has no impact on our fair value estimate, but it may foreshadow the outcome of Pfizer's patent battle
to thrive once again, as long as new management executes effectively. It looks as if CEO Richard Kogan is out and Pharmacia PHA chief Fred Hassan is in, but until the management transition is official, we recommend staying on the sidelines. Hassan will
The European Commission finally approved the merger of Pfizer PFE and Pharmacia PHA on Thursday. It's conditional on the disposition of several projects under development, but the only one with economic significance
product sales. While Vioxx is holding its own against Celebrex, both drugs are giving up share to Pfizer and Pharmacia's PHA Bextra, a second-generation COX-2 inhibitor. Merck's competing drug, Arcoxia, is still being tested, and we don
On Wednesday, Pharmacia PHA released 2002 earnings of $1.55 per share, an 8% increase from last year and in line with our expectations. Excluding Ambien
taking its medicine by ousting CEO Richard Kogan, and could be get back on track if CEO hopeful Fred Hassan (from Pharmacia PHA ) changes the company culture, but we're not ready to commit to investing. We'll wait and see how the executive transition
fund's above-average health-care stake didn't help matters much either, as big-cap drugmakers Merck mrk and Pharmacia pha slumped. Consequently, the fund dropped 6% and lagged 53% of its peers for the year. That showing came on the heels of a